# Hagop M. Kantarjian

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hagop-m-kantarjian/

## Facts

| Field | Value |
| --- | --- |
| Citations | 271,069 |
| Field | Acute Myeloid Leukemia Research |
| h-index | 233 |
| i10-index | 2,526 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5090435894 |
| ORCID iD | https://orcid.org/0000-0002-1908-3307 |
| Works | 5,585 |

## Researcher papers

- [European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia](https://scholariq.org/papers/european-leukemianet-2020-recommendations-for-treating-chronic-myeloid-leukemia/)
- [Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia](https://scholariq.org/papers/long-term-results-of-the-fludarabine-cyclophosphamide-and-rituximab-regimen-as/)
- [Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia](https://scholariq.org/papers/chemoimmunotherapy-with-fludarabine-cyclophosphamide-and-rituximab-for-relapsed/)
- [Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I](https://scholariq.org/papers/efficacy-safety-and-survival-with-ruxolitinib-in-patients-with-myelofibrosis/)
- [Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation](https://scholariq.org/papers/clinical-outcomes-and-prognostic-factors-in-patients-with-richter-s-syndrome/)
- [Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/chronic-myeloid-leukemia-version-1-2019-nccn-clinical-practice-guidelines-in/)
- [DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia](https://scholariq.org/papers/dna-methylation-changes-after-5-aza-2-deoxycytidine-therapy-in-patients-with/)
- [High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia](https://scholariq.org/papers/high-dose-vincristine-sulfate-liposome-injection-for-advanced-relapsed-and/)

## Researcher topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.